Turning basic research into new treatment for the most aggressive forms of breast cancer

Thirty years ago, Gail Sonenshein was studying cancer in immune cells when she read an article in the New York Times that would shape the rest of her career. The article described a new residency program in women’s health, part of an effort to improve treatment and outcomes for women at a time when most medical knowledge came from exclusively studying men.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart